Rat Anti-IL7R Recombinant Antibody (A7R34) (CBMAB-C2995WJ)

Name: Rat Anti-IL7R Recombinant Antibody (A7R34)
SKU: CBMAB-C2995WJ
Rating: 5 (1 reviews)

See all IL7R antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Rat

Clone

A7R34

Application

FC, FuncS, IHC-Fr, IP, Neut

Specificity

Mouse

Antibody Isotype

IgG2a, κ

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

PBS, pH 7.2

Preservative

0.09% sodium azide

Concentration

0.5 mg/mL

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Interleukin 7 Receptor

Introduction

The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]

Entrez Gene ID

16197

UniProt ID

P16872

Alternative Names

Interleukin 7 Receptor

Function

Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP).

Biological Process

B cell proliferationIEA:Ensembl
Cell morphogenesisIEA:Ensembl
Cell surface receptor signaling pathwayManual Assertion Based On ExperimentTAS:ProtInc
Defense response to Gram-positive bacteriumIEA:Ensembl
Homeostasis of number of cellsIEA:Ensembl
Immune responseManual Assertion Based On ExperimentTAS:ProtInc
Lymph node developmentIEA:Ensembl
Negative regulation of T cell apoptotic processIEA:Ensembl
Negative regulation of T cell mediated cytotoxicityIEA:Ensembl
Positive regulation of cell population proliferationManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of gene expressionIEA:Ensembl
Positive regulation of receptor signaling pathway via STATManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of T cell differentiation in thymusIEA:Ensembl
Regulation of cell sizeIEA:Ensembl
Regulation of DNA recombinationManual Assertion Based On ExperimentTAS:ProtInc
Signal transductionManual Assertion Based On ExperimentTAS:ProtInc
T cell differentiationIEA:Ensembl

Cellular Location

Isoform 1&3: Cell membrane
Isoform 4: Secreted

Involvement in disease

Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID):
A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Multiple sclerosis 3 (MS3):
A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease.

Topology

Extracellular: 21-239
Helical: 240-264
Cytoplasmic: 265-459

PTM

N-glycosylated IL-7Ralpha binds IL7 300-fold more tightly than the unglycosylated form.

Lee, K. Y., Ho, S. C., Sun, W. L., Feng, P. H., Lin, C. W., Chen, K. Y., ... & Wu, S. M. (2022). Lnc-IL7R alleviates PM2. 5-mediated cellular senescence and apoptosis through EZH2 recruitment in chronic obstructive pulmonary disease. Cell Biology and Toxicology, 38(6), 1097-1120.

Oliveira, M. L., Veloso, A., Garcia, E. G., Iyer, S., Pereira, C., Barreto, V. M., ... & Barata, J. T. (2022). Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia. Leukemia, 36(6), 1533-1540.

Wang, X., Chang, S., Wang, T., Wu, R., Huang, Z., Sun, J., ... & Mao, Y. (2022). IL7R is correlated with immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Frontiers in pharmacology, 13, 857289.

Berna, R., Mitra, N., Lou, C., Wan, J., Hoffstad, O., Wubbenhorst, B., ... & Margolis, D. J. (2021). Thymic stromal lymphopoietin and IL7R variants are associated with persistent atopic dermatitis. The Journal of investigative dermatology, 141(2), 446.

Abdelrasoul, H., Vadakumchery, A., Werner, M., Lenk, L., Khadour, A., Young, M., ... & Jumaa, H. (2020). Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature Communications, 11(1), 3194.

Kim, R., Boissel, N., Touzart, A., Leguay, T., Thonier, F., Thomas, X., ... & GRAALL group. (2020). Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation. Leukemia, 34(7), 1730-1740.

Al-Mossawi, H., Yager, N., Taylor, C. A., Lau, E., Danielli, S., de Wit, J., ... & Fairfax, B. P. (2019). Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele. Nature Communications, 10(1), 4575.

Leung, G. A., Cool, T., Valencia, C. H., Worthington, A., Beaudin, A. E., & Forsberg, E. C. (2019). The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development. Development, 146(14), dev176180.

Alsadeq, A., Lenk, L., Vadakumchery, A., Cousins, A., Vokuhl, C., Khadour, A., ... & Jumaa, H. (2018). IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia. Blood, The Journal of the American Society of Hematology, 132(15), 1614-1617.

Fan, Y., Nan, Y., Huang, J., Zhong, H., & Zhou, W. (2018). Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer. Bioscience reports, 38(3), BSR20180483.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Rat Anti-IL7R Recombinant Antibody (A7R34)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Antibody Pairs

IL7R Matched Antibody Pair (639) (CAT#: APMAB-639LY)

Related Products

Rat Anti-IL7R Recombinant Antibody (73N8F2) (CAT#: CBMAB-I1620-YY)

Rat Anti-IL7R Recombinant Antibody (CBWJC-3843) (CAT#: CBMAB-C5120WJ)

Mouse Anti-IL7R Recombinant Antibody (CBWJC-2204) (CAT#: CBMAB-C2996WJ)

Rat Anti-IL7R Recombinant Antibody (SB/199) (CAT#: CBMAB-C11745-LY)

Mouse Anti-IL7R Recombinant Antibody (MB15-18C9) (CAT#: CBMAB-C1789-CQ)

Mouse Anti-IL7R Recombinant Antibody (CBWJC-2206) (CAT#: CBMAB-C2998WJ)

Mouse Anti-IL7R Recombinant Antibody (CBYY-I1048) (CAT#: CBMAB-I2216-YY)

Rat Anti-IL7R Recombinant Antibody (AG115) (CAT#: V2LY-0524-LY79)

Rat Anti-IL7R Recombinant Antibody (CBYY-I1195) (CAT#: CBMAB-I2364-YY)

Mouse Anti-IL7R Recombinant Antibody (CBYY-I0239) (CAT#: CBMAB-I0620-YY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry